GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Wai, Christine  (4)
Material
Publisher
Language
Years
Subjects(RVK)
  • 1
    In: Journal of Bone and Mineral Research, Wiley, Vol. 26, No. 9 ( 2011-09), p. 2068-2081
    Abstract: Integrin‐associated protein (IAP/CD47) has been implicated in macrophage‐macrophage fusion. To understand the actions of CD47 on skeletal remodeling, we compared Cd47 −/− mice with Cd47 +/+ controls. Cd47 −/− mice weighed less and had decreased areal bone mineral density compared with controls. Cd47 −/− femurs were shorter in length with thinner cortices and exhibited lower trabecular bone volume owing to decreased trabecular number and thickness. Histomorphometry revealed reduced bone‐formation and mineral apposition rates, accompanied by decreased osteoblast numbers. No differences in osteoclast number were observed despite a nonsignificant but 40% decrease in eroded surface/bone surface in Cd47 −/− mice. In vitro, the number of functional osteoclasts formed by differentiating Cd47 −/− bone marrow cells was significantly decreased compared with wild‐type cultures and was associated with a decrease in bone‐resorption capacity. Furthermore, by disrupting the CD47–SHPS‐1 association, we found that osteoclastogenesis was markedly impaired. Assays for markers of osteoclast maturation suggested that the defect was at the point of fusion and not differentiation and was associated with a lack of SHPS‐1 phosphorylation, SHP‐1 phosphatase recruitment, and subsequent dephosphorylation of non–muscle cell myosin IIA. We also demonstrated a significant decrease in osteoblastogenesis in bone marrow stromal cells derived from Cd47 −/− mice. Our finding of cell‐autonomous defects in Cd47 −/− osteoblast and osteoclast differentiation coupled with the pronounced skeletal phenotype of Cd47 −/− mice support the conclusion that CD47 plays an important role in regulating skeletal acquisition and maintenance through its actions on both bone formation and bone resorption. © 2011 American Society for Bone and Mineral Research
    Type of Medium: Online Resource
    ISSN: 0884-0431 , 1523-4681
    URL: Issue
    RVK:
    Language: English
    Publisher: Wiley
    Publication Date: 2011
    detail.hit.zdb_id: 2008867-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Journal of Bone and Mineral Research, Wiley, Vol. 26, No. 11 ( 2011-11), p. 2792-2792
    Type of Medium: Online Resource
    ISSN: 0884-0431
    RVK:
    Language: English
    Publisher: Wiley
    Publication Date: 2011
    detail.hit.zdb_id: 2008867-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Journal of Bone and Mineral Research, Wiley, Vol. 27, No. 6 ( 2012-06), p. 1436-1436
    Type of Medium: Online Resource
    ISSN: 0884-0431
    RVK:
    Language: English
    Publisher: Wiley
    Publication Date: 2012
    detail.hit.zdb_id: 2008867-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    In: Journal of Bone and Mineral Research, Wiley, Vol. 27, No. 2 ( 2012-02), p. 390-400
    Abstract: Global deletion of the Igfbp2 gene results in the suppression of bone turnover. To investigate the role of insulin‐like growth factor‐binding protein‐2 (IGFBP‐2) in regulating osteoclast differentiation, we cultured Igfbp2 −/− bone marrow cells and found a reduction in the number of osteoclasts and impaired resorption. Addition of full‐length IGFBP‐2 restored osteoclast differentiation, fusion, and resorption. To determine the molecular domains of IGFBP‐2 that were required for this effect to be manifest, Igfbp2 −/− bone marrow cells were transfected with constructs in which the heparin‐binding (HBD) or the IGF‐binding domains of IGFBP‐2 were mutated. We found that both domains were necessary for osteoclastogenesis because expression of the mutated forms of either domain failed to support the formation of functionally mature osteoclasts. To discern the mechanism by which IGFBP‐2 regulates osteoclast formation, PTEN abundance and phosphorylation status as well as AKT responsiveness to IGF‐I were analyzed. Igfbp2 −/− cells had elevated levels of PTEN and phospho‐PTEN compared with controls. Expression of wild‐type IGFBP‐2 reduced the level of PTEN to that of wild‐type cells. Cells expressing the IGF‐binding mutant showed suppression of PTEN and phospho‐PTEN equivalent to the wild‐type protein, whereas those expressing the IGFBP‐2 HBD mutant showed no PTEN suppression. When the ability of IGF‐I to stimulate AKT activation, measured by Thr 308 and Ser 473 phosphorylation, was analyzed, stimulation of Ser 473 in response to IGF‐I in preosteoclasts required the presence of intact IGFBP‐2. This effect was duplicated by the addition of a CK2 inhibitor that prevents the phosphorylation of PTEN. In contrast, in fully differentiated osteoclasts, stimulation of Thr 308 phosphorylation required the presence of intact IGFBP‐2. We conclude that IGFBP‐2 is an important regulator of osteoclastogenesis and that both the heparin‐ and the IGF‐binding domains of IGFBP‐2 are essential for the formation of fully differentiated and functional osteoclasts. © 2012 American Society for Bone and Mineral Research
    Type of Medium: Online Resource
    ISSN: 0884-0431 , 1523-4681
    URL: Issue
    RVK:
    Language: English
    Publisher: Wiley
    Publication Date: 2012
    detail.hit.zdb_id: 2008867-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...